A phase Ib study investigating the combination of everolimus and dovitinib in vascular endothelial growth factor refractory clear cell renal cancer.
Powles, Thomas
A phase Ib study investigating the combination of everolimus and dovitinib in vascular endothelial growth factor refractory clear cell renal cancer. [electronic resource] - European journal of cancer (Oxford, England : 1990) Aug 2014 - 2057-64 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
1879-0852
10.1016/j.ejca.2014.04.021 doi
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Benzimidazoles--administration & dosage
Carcinoma, Renal Cell--drug therapy
Cohort Studies
Disease-Free Survival
Dose-Response Relationship, Drug
Everolimus
Fatigue--chemically induced
Female
Humans
Kaplan-Meier Estimate
Kidney Neoplasms--drug therapy
Male
Middle Aged
Quinolones--administration & dosage
Sirolimus--administration & dosage
A phase Ib study investigating the combination of everolimus and dovitinib in vascular endothelial growth factor refractory clear cell renal cancer. [electronic resource] - European journal of cancer (Oxford, England : 1990) Aug 2014 - 2057-64 p. digital
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
1879-0852
10.1016/j.ejca.2014.04.021 doi
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Benzimidazoles--administration & dosage
Carcinoma, Renal Cell--drug therapy
Cohort Studies
Disease-Free Survival
Dose-Response Relationship, Drug
Everolimus
Fatigue--chemically induced
Female
Humans
Kaplan-Meier Estimate
Kidney Neoplasms--drug therapy
Male
Middle Aged
Quinolones--administration & dosage
Sirolimus--administration & dosage